You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This series aims to highlight the latest clinical and experimental techniques and methods used to investigate fundamental questions in treating Heart Failure, from devices to surgical approaches. Review articles or opinions on methodologies or applications including the advantages and limitations of each are welcome. This Topic includes technologies and up-to-date methods which help advance science. The contributions to this collection will undergo peer review. Novelty may vary, but the utility of a method or protocol must be evident. We welcome contributions covering all aspects of treatment for Heart Failure that explore device solutions or surgical approaches. Submissions will be handled ...
The autonomic nervous system (ANS) plays a central role in the pathogenesis of several cardiovascular diseases such as hypertension, pulmonary hypertension, myocardial infarction, atrial fibrillation, ventricular tachyarrhythmias/fibrillation (VT/VF) and heart failure. Cardiovascular diseases (CVDs) are the leading cause of death -globally, taking an estimated 17.9 million lives each year ( 31 % of all deaths worldwide ). Mechanisms implicated in the pathophysiology of CVD include autonomic nervous system (ANS) dysfunction, endothelial dysfunction , vasoconstriction, and systemic inflammation. Today, several therapeutic options are available to treat heart and cardiovascular patients, mainly...
The American Heart Association’s Scientific Sessions 2019 is bringing big science, big technology, and big networking opportunities to Philadelphia, Pennsylvania this November. This event features five days of the best in science and cardiovascular clinical practice covering all aspects of basic, clinical, population and translational content.
The American Heart Association’s Scientific Sessions 2016 is bringing big science, big technology, and big networking opportunities to New Orleans, Louisiana this November. This event features five days of the best in science and cardiovascular clinical practice covering all aspects of basic, clinical, population and translational content.
This second edition volume expands on the previous edition with updated techniques and discussions on topics such as gene suppression, editing, and reprogramming; cardiac gene therapy vectors and promoters; cardiac gene delivery methods; pulmonary hypertension; and patient screening and measuring the efficacy of cardiac gene therapy. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Cutting-edge and comprehensive, Cardiac Gene Therapy: Methods and Protocols, Second Edition is a valuable tool for researchers in cardiology who are conducting gene therapy research. This book will lead to further advancements and successful clinical translations in the field. Chapter “Direct Reprogramming of Adult Human Cardiac Fibroblasts into Induced Cardiomyocytes Using miRcombo” is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
This book constitutes the refereed proceedings of the 17th Australian Conference on Artificial Intelligence, AI 2004, held in Cairns, Australia, in December 2004. The 78 revised full papers and 62 revised short papers presented were carefully reviewed and selected from 340 submissions. The papers are organized in topical sections on agents; biomedical applications; computer vision, image processing, and pattern recognition; ontologies, knowledge discovery and data mining; natural language and speech processing; problem solving and reasoning; robotics; and soft computing.